Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 451.40
-3.30 (-0.73%)
Sep 7, 2026, 12:00 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 102.38 billion as of September 4, 2026. Its market cap has decreased by -27.66% in one year.
Market Cap
102.38B
Enterprise Value
125.37B
Revenue
28.44B
Ranking
n/a
PE Ratio
37.09
Stock Price
451.40
ChartMarket Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 102.38B, an increase of 1,641.22%. That is a compound annual growth rate of 10.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 102.38B | -16.86% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.32T |
| Genmab | 129.25B |
| Demant | 61.54B |
| ALK-Abelló | 46.33B |
| H. Lundbeck | 43.68B |
| Zealand Pharma | 20.80B |
| Ambu A/S | 17.95B |
| Bavarian Nordic | 16.32B |